On March 11, 2011, Solazyme, Inc., a San Francisco, CA-based developer and supplier of algal oil and bioproducts for the fuels and chemicals, nutrition, and skin and personal care markets, filed an S-1 registration statement to go public through a $100m initial public offering of its common stock.
Solazyme intends to list its shares on the Nasdaq Global Market under the symbol “SZYM.”
Morgan Stanley and Goldman, Sachs & Co. are acting as lead underwriters.
In the last eighteen months, the company has received $21M Grant from US Department of Energy (DOE) and has closed a series D financing round with Braemar Energy Ventures, Morgan Stanley, Lightspeed Venture Partners, The Roda Group, Harris and Harris Group, VantagePoint Venture Partners, Zygote Ventures, Keating Capital, CTTV Investments LLC, San-Ei Gen, Bunge Limited (NYSE:BG), and Sir Richard Branson.
FinSMEs
19/03/2011
[youtube http://www.youtube.com/watch?v=LLLVzpTWmts]